Dr. Sekijima is the Professor and Chairman of the Department of Medicine (Neurology & Rheumatology) at Shinshu University School of Medicine, Matsumoto, Japan. He graduated from the Shinshu University School of Medicine in 1991, and his postgraduate training included internal medicine, neurology, clinical genetics, molecular genetics, and amyloidosis. As a postdoctoral fellow in Prof. Kelly’s lab at the Scripps Research Institute from 2002 to 2004, it was here that he elucidated the biological and chemical basis for tissue-selective transthyretin amyloid disease and started his research on the clinical application of transthyretin tetramer stabilizers. The clinical trials for these studies were conducted upon his return to Shinshu University as a professor. Dr. Yoshiki Sekijima is a board-certified internist, neurologist, rheumatologist, and clinical geneticist. His scientific interests are in the field of systemic amyloidoses, especially transthyretin amyloidosis, and neurodegenerative diseases (protein misfolding diseases) including Alzheimer’s disease and Parkinson’s disease. He is a member of the International Society of Amyloidosis (Member of the Nomenclature Committee) and the World Federation of Neurology, and a board member of the Japanese Society of Amyloidosis, the Japanese Peripheral Nerve Society, and the Japanese Society for Neuroinfectious Diseases.